耆鹿逐痹胶囊联合西药治疗绝经后骨质疏松症疗效
Clinical efficacy of Qilu Zhubi Capsules combined with Western medicine in the treatment of postmenopausal osteoporosis
  
DOI:10.3969/j.issn.1006-7108.2025.08.012
中文关键词:  绝经后骨质疏松症  肝肾阴虚  耆鹿逐痹胶囊  骨密度  平衡能力  跌倒风险
英文关键词:postmenopausal osteoporosis  yin deficiency of liver and kidney  Qilu Zhubi capsule  bone density  balance ability  fall risk
基金项目:国家自然科学基金(82074183);浙江省自然科学基金(LZ22H270002);浙江省中医药科技计划中医药现代化专项基金(2020ZX009)
作者单位
蒋欣1 杨小龙1 张泽臣1 汪成杰1 吴振宇1 李钰祎1 李威1 叶佰盛1 黄振1 史晓林2* 1.浙江中医药大学第二临床医学院, 浙江 杭州310053 2.浙江中医药大学附属第二医院浙江 杭州310005 
摘要点击次数: 247
全文下载次数: 0
中文摘要:
      目的 探究耆鹿逐痹胶囊对肝肾阴虚型绝经后骨质疏松症患者骨密度、平衡能力及跌倒、骨折风险的影响。方法 将2024年6月至2024年12月于浙江中医药大学附属第二医院就诊的70例肝肾阴虚型绝经后骨质疏松症患者随机分为对照组和治疗组,每组各35例。对照组予阿仑膦酸钠片+骨化三醇胶丸+碳酸钙D3片三联药治疗,治疗组则是在对照组基础上加用耆鹿逐痹胶囊治疗,比较两组患者的骨密度、平衡能力、跌倒风险和跌倒及骨折发生率。结果 (1)研究期间,对照组和治疗组分别有4例和5例患者脱落,最终共61例患者完成研究;(2)治疗前:两组各项观测指标均相似(P>0.05);(3)治疗后:①骨密度:治疗6个月后,两组骨密度T值均较治疗前显著升高(P<0.05),且组间比较发现治疗组升高更多,但差异无统计学意义(P>0.05);②平衡能力:治疗3、6个月后,两组平衡能力测试评分均较治疗前显著改善(P<0.05),治疗6个月后治疗组的平衡能力改善程度更佳(P<0.05);③跌倒风险:除了治疗3个月后的对照组,其余跌倒效能评分与治疗前相比均显著升高(P<0.05),治疗6个月后,治疗组的跌倒风险降低程度更加明显(P<0.05);(4)跌倒及骨折发生率:治疗期间对照组跌倒8次(25.81%)、骨折2次(6.45%);治疗组跌倒5次(16.67%)、骨折1次(3.33%)。结论 耆鹿逐痹胶囊联合西药治疗可以有效地提升患者的骨密度、改善平衡能力、降低跌倒及骨折风险。
英文摘要:
      Objective To investigate the effects of Qilu Zhubi Capsule on bone mineral density, balance ability and risk of fall and fracture in patients with liver-kidney yin deficiency type postmenopausal osteoporosis. Methods Seventy patients with liver-kidney-yin deficiency type postmenopausal osteoporosis who attended the Second Hospital of Zhejiang University of Traditional Chinese Medicine from June 2024 to December 2024 were randomly divided into a control group and a treatment group, with 35 patients in each group. The control group was treated with triple combination of alendronate tablets + osteotriol gel pills + calcium carbonate D3 tablets, while the treatment group was treated with Qilu Zhubi Capsules on top of the control group, comparing the bone mineral density, balance ability, fall risk and incidence of fall and fracture of the patients in the two groups. Results (1) During the study period, 4 patients in the control group and 5 patients in the treatment group fell off, and finally a total of 61 patients completed the study; (2) Before treatment: all the observations were similar in the two groups (P>0.05); (3) After treatment: ① Bone mineral density: after 6 months of treatment, the T-value of bone mineral density of the two groups were significantly higher than that of before treatment (P<0.05), and the comparison between the groups found that it was higher in the treatment group, but the difference was not statistically significant (P>0.05); ② Balance: after 3 and 6 months of treatment, the balance test scores of both groups were significantly improved compared with the pre-treatment (P<0.05), and the improvement of balance was better in the treatment group after 6 months of treatment (P<0.05); ③ Risk of fall: except for the control group after 3 months of treatment, all the fall efficacy scores were significantly higher compared with the pre-treatment (P<0.05), and after 6 months of treatment, the reduction of fall risk in the treatment group was more obvious (P<0.05); (4) Incidence of fall and fracture: during the treatment period, the control group suffered 8 falls (25.81%) and 2 fractures (6.45%); the treatment group suffered 5 falls (16.67%) and 1 fracture (3.33%). Conclusion Qilu Zhubi Capsules combined with western medicine treatment can effectively enhance patients' bone mineral density, improve balance, and reduce the risk of fall and fracture.
查看全文  查看/发表评论  下载PDF阅读器
关闭
function PdfOpen(url){ var win="toolbar=no,location=no,directories=no,status=yes,menubar=yes,scrollbars=yes,resizable=yes"; window.open(url,"",win); } function openWin(url,w,h){ var win="toolbar=no,location=no,directories=no,status=no,menubar=no,scrollbars=yes,resizable=no,width=" + w + ",height=" + h; controlWindow=window.open(url,"",win); } &et=3C06DB566315F8DC78C14CE21C0BF806CDE69BBBCC7EEB0B86E06341002A05FA495400A3F26AE0D8D61F5546F9C90DBD6A82DD727D08CB542958847125AA4C50E6E46CF70D0248639416FA07917D0157561966BB1ECE61E86AEF5803618ADC0786D9374EA2B74E0A436F17FECB210B2F31D7D4202A4DCCDA&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=527A01A248DACB72&jid=CA678592D11E309E8E3FB3B2BFE9BE1A&yid=E6A891D2134F30C0&aid=&vid=&iid=5D311CA918CA9A03&sid=778972EBEFCE1267&eid=A60ED5C9472B8BEB&fileno=202508012&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="527A01A248DACB72"; var my_jid="CA678592D11E309E8E3FB3B2BFE9BE1A"; var my_yid="E6A891D2134F30C0"; var my_aid="";